Prothelia Revenue and Competitors

Boston, MA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Prothelia's estimated annual revenue is currently $1.1M per year.(i)
  • Prothelia's estimated revenue per employee is $155,000

Employee Data

  • Prothelia has 7 Employees.(i)
  • Prothelia grew their employee count by -61% last year.

Prothelia's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M1-50%N/AN/A
#3
$5.1M3322%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M2-60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
N/A1110%N/AN/A
#10
$5.4M290%N/AN/A
Add Company

What Is Prothelia?

Prothelia is developing recombinant human Laminin-111 (rhLAM-111) for treatment of congenital muscular dystrophy type 1A. This form of muscular dystrophy is also referred to as MDC1A, Merosin deficiency or LAMA2 deficiency.

keywords:N/A

N/A

Total Funding

7

Number of Employees

$1.1M

Revenue (est)

-61%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.8M7-30%$19.6M
#2
$0.8M7-22%N/A
#3
$0.5M7N/AN/A
#4
$0.5M7N/AN/A
#5
$0.1M7-12%$7M